What is the current value of the next generation sequencing market?

The market is valued at USD 10.39 billion in 2025 and is forecast to reach USD 18.26 billion by 2030. Read More

Which product category generates the most recurring revenue?

Reagents and consumables command 69.88% of revenue, reflecting the repeat-purchase nature of sequencing chemistry and flow cells. Read More

Why is Asia-Pacific the fastest-growing region?

Rising healthcare investments, oncology burden, and government-funded genome projects lift Asia-Pacific to a 14.21% forecast CAGR. Read More

How does the new U.S. LDT rule affect market participants?

Laboratories must phase in quality-system and validation requirements through 2028, raising compliance costs but standardizing test performance. Read More

Which sequencing type is expanding fastest?

Whole exome sequencing grows at 14.23% CAGR as clinicians adopt it for rare disease diagnostics. Read More

What strategic moves are leading companies making?

Illumina partners with NVIDIA for multiomic analytics, Element Biosciences raises significant funding for low-cost platforms, and Roche advances nanopore technology to diversify clinical offerings. Read More

Next-generation Sequencing (NGS) Companies

This report lists the top Next-generation Sequencing (NGS) companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Next-generation Sequencing (NGS) industry.